Johnson and Johnson (J&J)
subsidiary, Janssen, has formed a
new group targeting “unmet global
health demands.”
The Janssen Global Public Health
(Janssen GPH) group would focus on
developing and introducing its most
promising medicines, the coy said.
Janssen worldwide chairman
Paul Stoffels said it was essential
to emphasise the needs of the
developing world in equal measure
to those of the developed.
The group would be responsible
for clinical and product development
and creating and implementing new
access strategies, he added.
For more, CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 24 Jan 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Jan 14
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.